SCHEMBL16385671

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL29453908	1.00	CA12 (0.41)	CA12CA1CA2CA9TNF
	SCHEMBL17811581	0.98	SIGMAR1 (0.41)	CA12CA1CA2CA9TNF
	SCHEMBL17470350	0.97	SIGMAR1 (0.42)	CA12CA1CA2CA9TNF
	SCHEMBL10136065	0.95	CA12 (0.46)	CA12CA1CA2CA9TNF
	SCHEMBL17740514	0.95	SIGMAR1 (0.43)	CA12CA1CA2CA9TNF
	SCHEMBL25580589	0.94	CA12 (0.37)	CA12CA1CA2CA9TNF
	SCHEMBL25580583	0.94	CA12 (0.37)	CA12CA1CA2CA9TNF
	SCHEMBL23108469	0.94	CA12 (0.39)	CA12CA1CA2CA9TNF
	SCHEMBL10136055	0.94	CA12 (0.45)	CA12CA1CA2CA9TNF
	SCHEMBL16385728	0.94	SIGMAR1 (0.40)	CA12CA1CA2CA9TNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.